{"pmid":32475783,"title":"Selecting the Most Appropriate Oncological Treatment for Patients with Renal Masses During the COVID-19 Pandemic: Recommendations from a Referral Center.","text":["Selecting the Most Appropriate Oncological Treatment for Patients with Renal Masses During the COVID-19 Pandemic: Recommendations from a Referral Center.","Eur Urol Focus","Moschovas, Marcio Covas","Mazzone, Ellio","Puliatti, Stefano","Mottrie, Alexandre","Patel, Vipul","32475783"],"journal":"Eur Urol Focus","authors":["Moschovas, Marcio Covas","Mazzone, Ellio","Puliatti, Stefano","Mottrie, Alexandre","Patel, Vipul"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475783","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.euf.2020.05.005","topics":["Prevention"],"weight":1,"_version_":1668437834936090624,"score":9.490897,"similar":[{"pmid":32500431,"title":"Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center.","text":["Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center.","COVID-19 is rapidly spreading worldwide. Healthcare systems are struggling to properly allocate resources while ensuring cure for diseases outside of the infection. The aim of this study was to demonstrate how surgical activity was affected by the virus outbreak and show the changes in practice in a tertiary referral COVID-19 center. The official bulletins of the Italian National Institute for the Infectious Diseases \"L. Spallanzani\" were reviewed to retrieve the number of daily COVID-19 patients. Records of consecutive oncological and transplant procedures performed during the outbreak were reviewed. Patients with a high probability of postoperative intensive care unit (ICU) admission were considered as high risk and defined by an ASA score >/= III and/or a Charlson Comorbidity Index (CCI) >/= 6 and/or a Revised Cardiac Risk Index for Preoperative Risk (RCRI) >/= 3. 72 patients were operated, including 12 (16.6%) liver and kidney transplantations. Patients had few comorbidities (26.3%), low ASA score (1.9 +/- 0.5), CCI (3.7 +/- 1.3), and RCRI (1.2 +/- 0.6) and had overall a low risk of postoperative ICU admission. Few patients had liver cirrhosis (12.5%) or received preoperative systemic therapy (16.6%). 36 (50%) high-risk surgical procedures were performed, including major hepatectomies, pancreaticoduodenectomies, total gastrectomies, multivisceral resections, and transplantations. Despite this, only 15 patients (20.8%) were admitted to the ICU. Only oncologic cases and transplantations were performed during the COVID-19 outbreak. Careful selection of patients allowed to perform major cancer surgeries and transplantations without further stressing hospital resources, meanwhile minimizing collateral damage to patients.","Updates Surg","Berardi, Giammauro","Colasanti, Marco","Levi Sandri, Giovanni Battista","Del Basso, Celeste","Ferretti, Stefano","Laurenzi, Andrea","Guglielmo, Nicola","Meniconi, Roberto Luca","Antonini, Mario","D'Offizi, Gianpiero","Ettorre, Giuseppe Maria","32500431"],"abstract":["COVID-19 is rapidly spreading worldwide. Healthcare systems are struggling to properly allocate resources while ensuring cure for diseases outside of the infection. The aim of this study was to demonstrate how surgical activity was affected by the virus outbreak and show the changes in practice in a tertiary referral COVID-19 center. The official bulletins of the Italian National Institute for the Infectious Diseases \"L. Spallanzani\" were reviewed to retrieve the number of daily COVID-19 patients. Records of consecutive oncological and transplant procedures performed during the outbreak were reviewed. Patients with a high probability of postoperative intensive care unit (ICU) admission were considered as high risk and defined by an ASA score >/= III and/or a Charlson Comorbidity Index (CCI) >/= 6 and/or a Revised Cardiac Risk Index for Preoperative Risk (RCRI) >/= 3. 72 patients were operated, including 12 (16.6%) liver and kidney transplantations. Patients had few comorbidities (26.3%), low ASA score (1.9 +/- 0.5), CCI (3.7 +/- 1.3), and RCRI (1.2 +/- 0.6) and had overall a low risk of postoperative ICU admission. Few patients had liver cirrhosis (12.5%) or received preoperative systemic therapy (16.6%). 36 (50%) high-risk surgical procedures were performed, including major hepatectomies, pancreaticoduodenectomies, total gastrectomies, multivisceral resections, and transplantations. Despite this, only 15 patients (20.8%) were admitted to the ICU. Only oncologic cases and transplantations were performed during the COVID-19 outbreak. Careful selection of patients allowed to perform major cancer surgeries and transplantations without further stressing hospital resources, meanwhile minimizing collateral damage to patients."],"journal":"Updates Surg","authors":["Berardi, Giammauro","Colasanti, Marco","Levi Sandri, Giovanni Battista","Del Basso, Celeste","Ferretti, Stefano","Laurenzi, Andrea","Guglielmo, Nicola","Meniconi, Roberto Luca","Antonini, Mario","D'Offizi, Gianpiero","Ettorre, Giuseppe Maria"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500431","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s13304-020-00825-3","keywords":["covid-19","general surgery","surgical oncology"],"topics":["Prevention"],"weight":1,"_version_":1668804508795273217,"score":46.64998},{"pmid":32312591,"pmcid":"PMC7158818","title":"Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology.","text":["Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology.","Eur J Surg Oncol","Marano, Luigi","Marrelli, Daniele","Roviello, Franco","32312591"],"journal":"Eur J Surg Oncol","authors":["Marano, Luigi","Marrelli, Daniele","Roviello, Franco"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312591","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ejso.2020.04.004","keywords":["covid-19","cancer care","coronavirus","surgical oncology"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493527523330,"score":44.782364},{"pmid":32489502,"pmcid":"PMC7239583","title":"COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy.","text":["COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first officially reported in December 2019 in Wuhan City, Hubei province, China, and has since lead to a pandemic. Most cases result in minor symptoms such as cough, fever, sore throat, myalgia, fatigue, nausea, diarrhea, loss of smell, and abdominal pain. As of April 8, 2020, more than 1,485,000 cases of COVID-19 have been reported in more than 200 countries and territories, resulting in over 90,000 deaths. Outcomes are worse in elderly patients, particularly males, and those with comorbidities, but can affect any age group. The incidence of acute kidney injury in patients with COVID-19 infection is about 3-15%; and in patients with severe infection requiring care in the intensive care unit, the rates of acute kidney injury increased significantly from 15% to 50%. Acute kidney injury is an independent risk factor for mortality in COVID-19 patients. The nephrologists, as well as intensivists, are facing immense daily challenges while providing care for these patients in the inpatient setting as well as end-stage renal disease patients on chronic dialysis in both inpatient and outpatient settings. In the current review article, we discussed the epidemiology and etiology of acute kidney injury, management of acute kidney injury including renal replacement therapy options (both hemodialysis and peritoneal dialysis) for inpatient floor, as well as intensive care unit settings. We also discussed the challenges faced by the outpatient dialysis units with COVID-19 infection. We discussed measures required to limit the spread of infection, as well as summarized the guidance as per the Centers for Disease Control and Prevention (CDC), American Society of Nephrology (ASN), American Society of Diagnostic and Interventional Nephrology (ASDIN) and the Vascular Access Society of the Americas (VASA).","J Clin Med Res","Adapa, Sreedhar","Aeddula, Narothama Reddy","Konala, Venu Madhav","Chenna, Avantika","Naramala, Srikanth","Madhira, Bhaskar Reddy","Gayam, Vijay","Balla, Mamtha","Muppidi, Vijayadershan","Bose, Subhasish","32489502"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first officially reported in December 2019 in Wuhan City, Hubei province, China, and has since lead to a pandemic. Most cases result in minor symptoms such as cough, fever, sore throat, myalgia, fatigue, nausea, diarrhea, loss of smell, and abdominal pain. As of April 8, 2020, more than 1,485,000 cases of COVID-19 have been reported in more than 200 countries and territories, resulting in over 90,000 deaths. Outcomes are worse in elderly patients, particularly males, and those with comorbidities, but can affect any age group. The incidence of acute kidney injury in patients with COVID-19 infection is about 3-15%; and in patients with severe infection requiring care in the intensive care unit, the rates of acute kidney injury increased significantly from 15% to 50%. Acute kidney injury is an independent risk factor for mortality in COVID-19 patients. The nephrologists, as well as intensivists, are facing immense daily challenges while providing care for these patients in the inpatient setting as well as end-stage renal disease patients on chronic dialysis in both inpatient and outpatient settings. In the current review article, we discussed the epidemiology and etiology of acute kidney injury, management of acute kidney injury including renal replacement therapy options (both hemodialysis and peritoneal dialysis) for inpatient floor, as well as intensive care unit settings. We also discussed the challenges faced by the outpatient dialysis units with COVID-19 infection. We discussed measures required to limit the spread of infection, as well as summarized the guidance as per the Centers for Disease Control and Prevention (CDC), American Society of Nephrology (ASN), American Society of Diagnostic and Interventional Nephrology (ASDIN) and the Vascular Access Society of the Americas (VASA)."],"journal":"J Clin Med Res","authors":["Adapa, Sreedhar","Aeddula, Narothama Reddy","Konala, Venu Madhav","Chenna, Avantika","Naramala, Srikanth","Madhira, Bhaskar Reddy","Gayam, Vijay","Balla, Mamtha","Muppidi, Vijayadershan","Bose, Subhasish"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489502","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.14740/jocmr4160","keywords":["acute kidney injury","covid-19","end-stage renal disease","hemodialysis","hemofiltration","kidney impairment","peritoneal dialysis","renal replacement therapy"],"locations":["Wuhan","Hubei","China","myalgia","fatigue","diarrhea"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668623433623142401,"score":43.220375}]}